The FITC Anti-Human CD19 Antibody (HI19A) offered by Assay Genie is a cutting-edge tool for researchers investigating the role of CD19 in immune responses and related disorders. This monoclonal antibody, optimized for use in flow cytometry, immunofluorescence, and other immunological techniques, specifically targets the CD19 antigen present on human cells.CD19 is a key marker for B cell development and activation, making it a pivotal target for studying B cell-associated diseases such as leukemia, lymphoma, and autoimmune disorders. The HI19A antibody allows for precise detection and quantification of CD19-expressing cells in various biological samples, facilitating in-depth research into B cell biology and immunotherapy strategies.
With its high specificity and sensitivity, the FITC Anti-Human CD19 Antibody (HI19A) from Assay Genie provides researchers with a reliable tool to explore the complex roles of CD19 in health and disease. Whether investigating basic immunology mechanisms or developing novel treatments, this antibody is a valuable asset for advancing scientific knowledge in the field of immunology.
Each lot of this antibody is quality control tested by flow cytometric analysis. The amount of the reagent is suggested to be used 5 µL of antibody per test (million cells in 100 µL staining volume or per 100 µL of whole blood). Please check your vial before the experiment. Since applications vary, the appropriate dilutions must be determined for individual use.
Spectrum:
Swissprot:
P51677
Gene ID:
930
Storage Buffer:
Phosphate buffered solution, pH 7.2, containing 0.09% stabilizer and 1% protein protectant.
Stability & Storage:
Keep as concentrated solution. Store at 2~8°C and protected from prolonged exposure to light. Do not freeze. Centrifuge before opening to ensure complete recovery of vial contents. This product is guaranteed up to one year from purchase.
Background:
CD19 is a 95 kD type I transmembrane glycoprotein also known as B4. It is a member of the immunoglobulin superfamily expressed on B-cells (from pro-B to blastoid B cells, absent on plasma cells) and follicular dendritic cells. CD19 is involved in B cell development, activation, and differentiation. CD19 forms a complex with CD21 (CR2) and CD81 (TAPA-1), and functions as a BCR co-receptor.